Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Patient and physician preferences and satisfaction with oral and long-acting injectable antipsychotic treatment
2009-011343-39Phase 4Completed
- Sponsor
- Janssen-Cilag
- Start
- Apr 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of risperidone in schizophrenia, schizoaffective disorder, delusional disorder and 2 more (3 arms), sponsored by Janssen-Cilag. Started Apr 2009; status: completed.
02
Drugs
risperidone
03
Conditions
schizophreniaschizoaffective disorderdelusional disorderUnspecified psychosisSchizophrenia Spectrum Disorders (SSD)
Beyond the preview
Go deeper on 2009-011343-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-011343-39.